Literature DB >> 21127140

Targeting complement C5 in atypical hemolytic uremic syndrome.

David J Salant.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21127140     DOI： 10.1681/ASN.2010111145

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  11 in total

1.  A case of atypical hemolytic uremic syndrome in a second renal transplant.

Authors:  Nicholas A Zwang; Bing Ho; Yashpal S Kanwar; Brad Lewis; Matthew Cusick; John J Friedewald; Lorenzo Gallon
Journal:  J Nephrol       Date:  2017-02-21       Impact factor: 3.902

Review 2.  Hemolytic uremic syndrome.

Authors:  Caterina Mele; Giuseppe Remuzzi; Marina Noris
Journal:  Semin Immunopathol       Date:  2014-02-14       Impact factor: 9.623

3.  Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults.

Authors:  Véronique Fremeaux-Bacchi; Fadi Fakhouri; Arnaud Garnier; Frank Bienaimé; Marie-Agnès Dragon-Durey; Stéphanie Ngo; Bruno Moulin; Aude Servais; François Provot; Lionel Rostaing; Stéphane Burtey; Patrick Niaudet; Georges Deschênes; Yvon Lebranchu; Julien Zuber; Chantal Loirat
Journal:  Clin J Am Soc Nephrol       Date:  2013-01-10       Impact factor: 8.237

Review 4.  Atypical hemolytic uremic syndrome.

Authors:  Chantal Loirat; Véronique Frémeaux-Bacchi
Journal:  Orphanet J Rare Dis       Date:  2011-09-08       Impact factor: 4.123

5.  Treatment of atypical uraemic syndrome in the era of eculizumab.

Authors:  Veronique Fremeaux-Bacchi
Journal:  Clin Kidney J       Date:  2012-02

6.  Abrogation of immune complex glomerulonephritis by native carboxypeptidase and pharmacological antagonism of the C5a receptor.

Authors:  Jessy J Alexander; Lee D Chaves; Anthony Chang; Shruti Dighe; Alexander Jacob; Richard J Quigg
Journal:  Cell Mol Immunol       Date:  2015-07-13       Impact factor: 11.530

7.  Complement component 5 promotes lethal thrombosis.

Authors:  Tomohiro Mizuno; Kengo Yoshioka; Masashi Mizuno; Mie Shimizu; Fumihiko Nagano; Tomoyuki Okuda; Naotake Tsuboi; Shoichi Maruyama; Tadashi Nagamatsu; Masaki Imai
Journal:  Sci Rep       Date:  2017-02-16       Impact factor: 4.379

8.  A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the Staphylococcus aureus SSL7 Protein.

Authors:  Laure Yatime; Nicolas S Merle; Annette G Hansen; Niels Anton Friis; Jakob A Østergaard; Mette Bjerre; Lubka T Roumenina; Steffen Thiel; Peter Kristensen; Gregers R Andersen
Journal:  Front Immunol       Date:  2018-11-29       Impact factor: 7.561

Review 9.  Consensus regarding diagnosis and management of atypical hemolytic uremic syndrome.

Authors:  Hajeong Lee; Eunjeong Kang; Hee Gyung Kang; Young Hoon Kim; Jin Seok Kim; Hee-Jin Kim; Kyung Chul Moon; Tae Hyun Ban; Se Won Oh; Sang Kyung Jo; Heeyeon Cho; Bum Soon Choi; Junshik Hong; Hae Il Cheong; Doyeun Oh
Journal:  Korean J Intern Med       Date:  2020-01-02       Impact factor: 2.884

10.  The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice.

Authors:  Jessy J Alexander; Lee Chaves; Anthony Chang; Richard J Quigg
Journal:  Kidney Int       Date:  2012-07-25       Impact factor: 10.612
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.